Current Histopathologic and Molecular Characterisations of Prostate Cancer: Towards Individualised Prognosis and Therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 26070514.
- Also identified by DOI 10.1016/j.eururo.2015.05.041.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Data on TMPRSS2-ERG and AR-V7 may pave the way for personalised therapy for prostate cancer (PCa) patients. Comprehensive molecular profiling can help identify multiple PCa subtypes and driving alterations. Translating these findings into clinical practice is still challenging.
Medical subject headings
- Carcinoma
- Prostatic Neoplasms